AN ORGANIZATION STUDY CHAPTER ± I COMPANY PROFILE BANGALORE INSITUTE OF MANAGEMENT STUDIES Page 1 AN ORGANIZATION STUDY 1.1 INTRODUCTION OF ORGANIZATION GSK is one of the…

Slide 1Potato Vaccine against Hepatitis B PLANT & MAMMALIAN CELL TECHNOLOGY BSB3163 13 TH DEC 2011 BY: KALAISELVI MOHANRAJSB09031 RUBINI DEVI SELVARAJOOSB09005 SUMITHALAKSMY…

Slide 1 Prevention of Hepatitis A during outbreaks and post-exposure Paolo Bonanni Department of Public Health University of Florence, Italy Slide 2 Hepatitis A: epidemiological…

Slide 1 mHEALTH- The Way Forward DR. WAQAR ALI 1 Slide 2 Introduction  In an mHealth environment, Information Moves rather than the Physician or the Patient mHealth creates…

Slide 1 HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS Programme Slide…

Slide 1 Viral Diseases – Part II Viscerotropic & Neurotropic Viruses Nestor T. Hilvano, M.D., M.P.H. Slide 2 Learning Objectives You should be able to: 1.Describe the…

PREVAC B Management of hepatitis B prevention among migrants AUBERT Jean-Pierre, DI PUMPO Alexandrine, SANTANA Pascale, MAJERHOLC Catherine, PY Anne-Marie, TAULERA Olivier,…

Unit 11 Power Notes â Part 1 Science, Technology and Medicine in the mid to late 20th century (Chapter 24-26) 1950âs and 1960âs There was a high interest in science and…

Slide 1 Infection Prevention & Control Slide 2 Infection Prevention Policies and Procedures Administrative Manual: Section 4 Infection Control contains:  OSHA Bloodborne…

Slide 1 Prevention of Hepatitis B: the Foundation of Viral Hepatitis Prevention Harold S. Margolis, M.D. Division of Viral Hepatitis National Center for Infectious Diseases…